Results 121 to 130 of about 1,121 (157)
Some of the next articles are maybe not open access.
Canadian Journal of Health Technologies
Reimbursement reviews are comprehensive assessments of the clinical effectiveness and cost-effectiveness, as well as patient and clinician perspectives, of a drug or drug class. The assessments inform nonbinding recommendations that help guide the reimbursement decisions of Canada’s federal, provincial, and territorial governments, with the ...
openaire +1 more source
Reimbursement reviews are comprehensive assessments of the clinical effectiveness and cost-effectiveness, as well as patient and clinician perspectives, of a drug or drug class. The assessments inform nonbinding recommendations that help guide the reimbursement decisions of Canada’s federal, provincial, and territorial governments, with the ...
openaire +1 more source
Burosumab nell’ipofosfatemia XLH
L'Endocrinologo, 2020Marco Pitea, Elisa Sala, Stefano Mora
openaire +1 more source
The effect of burosumab on intact and C-terminal FGF23 measurements
Clinical Endocrinology, 2023Hajime Kato +2 more
exaly
Reply to: appropriate dosing of burosumab in tumor-induced osteomalacia
Osteoporosis International, 2022Crotti C. +4 more
openaire +3 more sources